Caption Management, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$366,324
-29.5%
373,8000.0%0.01%
-33.3%
Q2 2023$519,582
-66.2%
373,800
-61.3%
0.01%
-70.0%
Q1 2023$1,537,053
-86.0%
966,700
-45.2%
0.03%
-82.5%
Q4 2022$10,986,605
+73.8%
1,763,500
+86.8%
0.17%
+96.6%
Q3 2022$6,323,000
+2567.9%
943,900
+2430.6%
0.09%
+2800.0%
Q2 2022$237,000
-74.5%
37,300
-81.4%
0.00%
-72.7%
Q1 2022$928,000
+412.7%
200,000
+1233.3%
0.01%
+450.0%
Q3 2021$181,000
-96.4%
15,000
-93.8%
0.00%
-97.0%
Q2 2021$5,095,000
+23.5%
240,889
+63.7%
0.07%
-24.7%
Q1 2021$4,127,000
+236.3%
147,150
+345.9%
0.09%
+206.9%
Q3 2020$1,227,000
-53.6%
33,000
-35.9%
0.03%
-67.4%
Q2 2020$2,643,000
+23.8%
51,504
-23.9%
0.09%
-25.8%
Q1 2020$2,135,000
-67.4%
67,700
-38.5%
0.12%
-45.5%
Q4 2019$6,558,000
+177.8%
110,000
+70.8%
0.22%
+80.3%
Q3 2019$2,361,000
-62.4%
64,400
-52.3%
0.12%
-61.4%
Q2 2019$6,281,000
+56.0%
135,000
+54.3%
0.32%
-1.6%
Q4 2018$4,025,000
-39.5%
87,500
-41.7%
0.32%
-12.5%
Q3 2018$6,656,000150,0000.37%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders